Author response for "SGLT2 inhibitors and risk of diabetic ketoacidosis in patients with type 2 diabetes: systematic review and meta‐analysis of randomized controlled trials"
2020 ◽
2020 ◽
Vol 22
(9)
◽
pp. 1619-1627
◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
PDB3 SGLT2 Inhibitors and Risk of Diabetic Ketoacidosis in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials
2020 ◽
